Latest Asx Quarterly Reports News

Stonehorse Energy Limited reported steady operational and financial performance for Q1 2026, driven by successful drilling in Canada and solid oil and gas production across its North American portfolio.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Astral Resources has reported strong drilling results across its Western Australian gold projects, progressing the Mandilla Definitive Feasibility Study (DFS) and securing $1.76 million in a recent placement tranche. The company maintains a healthy cash position of $73 million as it targets first gold production in early 2028.

Admiralty Resources reported a $3.1 million cash outflow for the December quarter, with less than one quarter of funding available. Despite this, the company expects to maintain operations supported by iron ore sales and a significant prepayment.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

ARC Funds Limited reports a solid September quarter with a $634,000 equity placement, positive cash flow, and the successful integration of The Term Deposit Shop, positioning itself for further expansion.

Orion Minerals reported a net cash outflow of A$3.1 million for the September 2025 quarter but has secured an $8.6 million capital raise post-quarter to support ongoing project development and operations.

Bellevue Gold Limited reported robust cash flow for the September quarter, enabling a substantial early repayment on its project loan and maintaining a strong cash position.

Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.

M3 Mining Limited reports promising exploration progress at its Edjudina Gold and Victoria Bore Copper projects, while advancing talks to secure a strategic energy asset in North Africa ahead of a pivotal May shareholder meeting.

Peninsula Energy reported a $1.9 million operating cash outflow and $18.9 million investing spend on its Lance Project for Q1 2025, ending the quarter with $24.2 million in cash and an estimated 13 quarters of funding runway based on current outflows.